Bert Vogelstein
Impact in
- Oncology top 0.1%
- Cancer-related Molecular Pathways
- Cancer Research top 0.5%
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- K W Kinzler (3 shared papers)Victor E. Velculescu (2 shared papers)J.M. Trent (2 shared papers)Takashi Tokino (1 shared paper)Daniel B. Levy (1 shared paper)W E Mercer (1 shared paper)Ramon Parsons (1 shared paper)David Pei‐Cheng Lin (1 shared paper)
- Journals
- CHEST Journal (1 paper)Nature Genetics (1 paper)Genomics (1 paper)Annals of Oncology (1 paper)Cell (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Bert Vogelstein
16 papers receiving 10.4k citations
Bert Vogelstein's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 6.2k
- Cancer Research 1.7k
- Biotechnology 1.1k
- Molecular Biology 6.7k
- Pathology and Forensic Medicine 1.6k
Countries citing papers authored by Bert Vogelstein
This map shows the geographic impact of Bert Vogelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Vogelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Vogelstein more than expected).
Fields of papers citing papers by Bert Vogelstein
This network shows the impact of papers produced by Bert Vogelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Vogelstein. The network helps show where Bert Vogelstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Vogelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | WAF1, a potential mediator of p53 tumor suppression Hit paper breakdown → | 1993 | 7238 |
| 2 | APC mutations occur early during colorectal tumorigenesis Hit paper breakdown → | 1992 | 1501 |
| 3 | Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers Hit paper breakdown → | 1996 | 503 |
| 4 | 1992 | 307 | |
| 5 | Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. | 1990 | 275 |
| 6 | 1994 | 173 | |
| 7 | Infrequent p53 gene mutations in medulloblastomas. | 1991 | 163 |
| 8 | 2000 | 141 | |
| 9 | 1991 | 79 | |
| 10 | 1986 | 70 | |
| 11 | 1993 | 64 | |
| 12 | 1992 | 26 | |
| 13 | 1989 | 13 | |
| 14 | 1988 | 8 | |
| 15 | 2022 | 8 | |
| 16 | Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas. | 1991 | 5 |
About Bert Vogelstein
Bert Vogelstein is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Neurology, having authored 16 papers that have together received 10.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (5 papers), Neuroblastoma Research and Treatments (4 papers), Cancer-related Molecular Pathways (3 papers), Glioma Diagnosis and Treatment (2 papers), Cell Adhesion Molecules Research (2 papers), Cancer Research and Treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (6.2k citations), Cancer Research (1.7k citations), Biotechnology (1.1k citations), Molecular Biology (6.7k citations) and Pathology and Forensic Medicine (1.6k citations). Bert Vogelstein has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include K W Kinzler, Victor E. Velculescu, J.M. Trent, Takashi Tokino, Daniel B. Levy, W E Mercer, Ramon Parsons, David Pei‐Cheng Lin, Wafik S. El‐Deiry and Kathleen R. Cho. Their work appears in journals such as CHEST Journal, Nature Genetics, Genomics, Annals of Oncology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.